TW202440102A - 含多奈哌齊之經皮吸收製劑 - Google Patents

含多奈哌齊之經皮吸收製劑 Download PDF

Info

Publication number
TW202440102A
TW202440102A TW112139958A TW112139958A TW202440102A TW 202440102 A TW202440102 A TW 202440102A TW 112139958 A TW112139958 A TW 112139958A TW 112139958 A TW112139958 A TW 112139958A TW 202440102 A TW202440102 A TW 202440102A
Authority
TW
Taiwan
Prior art keywords
donepezil
weight
percutaneous absorption
preparation
present
Prior art date
Application number
TW112139958A
Other languages
English (en)
Chinese (zh)
Inventor
青木寛
中田生
川上智
Original Assignee
日商帝國製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商帝國製藥股份有限公司 filed Critical 日商帝國製藥股份有限公司
Publication of TW202440102A publication Critical patent/TW202440102A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW112139958A 2022-12-16 2023-10-19 含多奈哌齊之經皮吸收製劑 TW202440102A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022201243 2022-12-16
JP2022-201243 2022-12-16

Publications (1)

Publication Number Publication Date
TW202440102A true TW202440102A (zh) 2024-10-16

Family

ID=91485458

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112139958A TW202440102A (zh) 2022-12-16 2023-10-19 含多奈哌齊之經皮吸收製劑

Country Status (3)

Country Link
JP (1) JPWO2024127805A1 (enrdf_load_stackoverflow)
TW (1) TW202440102A (enrdf_load_stackoverflow)
WO (1) WO2024127805A1 (enrdf_load_stackoverflow)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
ES2652491T3 (es) * 2009-10-21 2018-02-02 Teikoku Seiyaku Co., Ltd. Preparación que contiene donepecilo de absorción transdérmica
US20120283670A1 (en) * 2009-12-16 2012-11-08 Takeshi Ito Percutaneous absorption preparation comprising anti-dementia drug
JP5795264B2 (ja) * 2009-12-16 2015-10-14 後藤 武 抗認知症薬物の経皮吸収製剤
JP6089339B2 (ja) * 2011-09-08 2017-03-08 株式会社 ケイ・エム トランスダーム 経皮吸収製剤
JP6894121B2 (ja) * 2015-12-10 2021-06-23 株式会社 ケイ・エム トランスダーム 経皮吸収製剤

Also Published As

Publication number Publication date
WO2024127805A1 (ja) 2024-06-20
JPWO2024127805A1 (enrdf_load_stackoverflow) 2024-06-20

Similar Documents

Publication Publication Date Title
JP5913981B2 (ja) ドネペジル含有経皮吸収型製剤
JP4394443B2 (ja) 経皮吸収型製剤
KR101454362B1 (ko) 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
JP5403948B2 (ja) メマンチン含有経皮吸収製剤
RU2713207C2 (ru) Трансдермальная композиция, содержащая донепезил в качестве активного ингредиента
JP4694967B2 (ja) 貼付剤
JP5632577B2 (ja) 貼付剤
WO2008026381A1 (en) Nail patch
US20080188509A1 (en) Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy
JP4758101B2 (ja) 貼付剤
JP4986411B2 (ja) 貼付剤
TW202440102A (zh) 含多奈哌齊之經皮吸收製劑
US8563031B2 (en) Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
EP1611882B1 (en) Adhesive patch
WO2013061588A1 (ja) 経皮吸収型製剤
CN109310526B (zh) 普拉克索经皮贴片系统与用法
TWI757253B (zh) 普拉克索經皮貼片系統與用法